世界のCox-2阻害剤市場予測（～2024年）

• 英文タイトル：Global Cox-2 Inhibitors Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR09D3883
• 出版社/出版日：GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、122ページ
• 納品方法：Eメール
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、Cox-2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、選択的Cox-2阻害剤、非選択的Cox-2阻害剤等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。Cox-2阻害剤の世界市場概観、企業動向、企業別Cox-2阻害剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・Cox-2阻害剤の市場概観
・Cox-2阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・Cox-2阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向
・Cox-2阻害剤の世界市場規模
・Cox-2阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等）
・Cox-2阻害剤のアメリカ市場規模推移
・Cox-2阻害剤のカナダ市場規模推移
・Cox-2阻害剤のメキシコ市場規模推移
・Cox-2阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・Cox-2阻害剤のドイツ市場規模推移
・Cox-2阻害剤のイギリス市場規模推移
・Cox-2阻害剤のロシア市場規模推移
・Cox-2阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・Cox-2阻害剤の日本市場規模推移
・Cox-2阻害剤の中国市場規模推移
・Cox-2阻害剤の韓国市場規模推移
・Cox-2阻害剤のインド市場規模推移
・Cox-2阻害剤の東南アジア市場規模推移
・Cox-2阻害剤の南米市場分析（ブラジル、アルゼンチン等）
・Cox-2阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・Cox-2阻害剤の種類別分析/販売量、売上、市場シェア（選択的Cox-2阻害剤、非選択的Cox-2阻害剤）
・Cox-2阻害剤の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局）
・Cox-2阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・Cox-2阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析

Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.

Scope of the Report:
The global Cox-2 Inhibitors market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cox-2 Inhibitors.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cox-2 Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cox-2 Inhibitors market by product type and applications/end industries.

Market Segment by Companies, this report covers
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

レポート目次

Table of Contents

1 Cox-2 Inhibitors Market Overview
1.1 Product Overview and Scope of Cox-2 Inhibitors
1.2 Classification of Cox-2 Inhibitors by Types
1.2.1 Global Cox-2 Inhibitors Revenue Comparison by Types (2019-2024)
1.2.2 Global Cox-2 Inhibitors Revenue Market Share by Types in 2018
1.2.3 Selective Cox-2 Inhibitors
1.2.4 Non Selective Cox-2 Inhibitors
1.3 Global Cox-2 Inhibitors Market by Application
1.3.1 Global Cox-2 Inhibitors Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Cox-2 Inhibitors Market by Regions
1.4.1 Global Cox-2 Inhibitors Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cox-2 Inhibitors Status and Prospect (2014-2024)
1.5 Global Market Size of Cox-2 Inhibitors (2014-2024)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Cox-2 Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Cox-2 Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Cox-2 Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Cox-2 Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.5 Cadila Pharmaceuticals
2.5.1 Business Overview
2.5.2 Cox-2 Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cadila Pharmaceuticals Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sabinsa Corporation
2.6.1 Business Overview
2.6.2 Cox-2 Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sabinsa Corporation Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cox-2 Inhibitors Market Competition, by Players
3.1 Global Cox-2 Inhibitors Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cox-2 Inhibitors Players Market Share
3.2.2 Top 10 Cox-2 Inhibitors Players Market Share
3.3 Market Competition Trend
4 Global Cox-2 Inhibitors Market Size by Regions
4.1 Global Cox-2 Inhibitors Revenue and Market Share by Regions
4.2 North America Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.3 Europe Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.5 South America Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5 North America Cox-2 Inhibitors Revenue by Countries
5.1 North America Cox-2 Inhibitors Revenue by Countries (2014-2019)
5.2 USA Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5.3 Canada Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5.4 Mexico Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6 Europe Cox-2 Inhibitors Revenue by Countries
6.1 Europe Cox-2 Inhibitors Revenue by Countries (2014-2019)
6.2 Germany Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.3 UK Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.4 France Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.5 Russia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.6 Italy Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cox-2 Inhibitors Revenue by Countries
7.1 Asia-Pacific Cox-2 Inhibitors Revenue by Countries (2014-2019)
7.2 China Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.3 Japan Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.4 Korea Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.5 India Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8 South America Cox-2 Inhibitors Revenue by Countries
8.1 South America Cox-2 Inhibitors Revenue by Countries (2014-2019)
8.2 Brazil Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8.3 Argentina Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8.4 Colombia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cox-2 Inhibitors by Countries
9.1 Middle East and Africa Cox-2 Inhibitors Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.3 UAE Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.4 Egypt Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.6 South Africa Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
10 Global Cox-2 Inhibitors Market Segment by Type
10.1 Global Cox-2 Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 Global Cox-2 Inhibitors Market Forecast by Type (2019-2024)
10.3 Selective Cox-2 Inhibitors Revenue Growth Rate (2014-2024)
10.4 Non Selective Cox-2 Inhibitors Revenue Growth Rate (2014-2024)
11 Global Cox-2 Inhibitors Market Segment by Application
11.1 Global Cox-2 Inhibitors Revenue Market Share by Application (2014-2019)
11.2 Cox-2 Inhibitors Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Cox-2 Inhibitors Market Size Forecast (2019-2024)
12.1 Global Cox-2 Inhibitors Market Size Forecast (2019-2024)
12.2 Global Cox-2 Inhibitors Market Forecast by Regions (2019-2024)
12.3 North America Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.4 Europe Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.6 South America Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Cox-2 Inhibitors Picture
Table Product Specifications of Cox-2 Inhibitors
Table Global Cox-2 Inhibitors and Revenue (Million USD) Market Split by Product Type
Figure Global Cox-2 Inhibitors Revenue Market Share by Types in 2018
Figure Selective Cox-2 Inhibitors Picture
Figure Non Selective Cox-2 Inhibitors Picture
Table Global Cox-2 Inhibitors Revenue (Million USD) by Application (2014-2024)
Figure Cox-2 Inhibitors Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Cox-2 Inhibitors Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Cox-2 Inhibitors Type and Applications
Table Bayer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cox-2 Inhibitors Type and Applications
Table Novartis Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cox-2 Inhibitors Type and Applications
Table Pfizer Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cox-2 Inhibitors Type and Applications
Table Merck Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharmaceuticals Cox-2 Inhibitors Type and Applications
Table Cadila Pharmaceuticals Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Sabinsa Corporation Basic Information, Manufacturing Base and Competitors
Table Sabinsa Corporation Cox-2 Inhibitors Type and Applications
Table Sabinsa Corporation Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cox-2 Inhibitors Revenue (Million USD) by Players (2014-2019)
Table Global Cox-2 Inhibitors Revenue Share by Players (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Share by Players in 2017
Figure Global Cox-2 Inhibitors Revenue Share by Players in 2018
Figure Global Top 5 Players Cox-2 Inhibitors Revenue Market Share in 2018
Figure Global Top 10 Players Cox-2 Inhibitors Revenue Market Share in 2018
Figure Global Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cox-2 Inhibitors Revenue (Million USD) by Regions (2014-2019)
Table Global Cox-2 Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Market Share by Regions in 2018
Figure North America Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Europe Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure South America Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table North America Cox-2 Inhibitors Revenue by Countries (2014-2019)
Table North America Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure USA Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Canada Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Mexico Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Europe Cox-2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure Germany Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure UK Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure France Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Russia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Italy Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cox-2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure China Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Japan Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Korea Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure India Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table South America Cox-2 Inhibitors Revenue by Countries (2014-2019)
Table South America Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Argentina Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Colombia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cox-2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure UAE Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Egypt Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Nigeria Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure South Africa Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Global Cox-2 Inhibitors Revenue (Million USD) by Type (2014-2019)
Table Global Cox-2 Inhibitors Revenue Share by Type (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Share by Type (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Share by Type in 2019
Table Global Cox-2 Inhibitors Revenue Forecast by Type (2019-2024)
Figure Global Cox-2 Inhibitors Market Share Forecast by Type (2019-2024)
Figure Global Selective Cox-2 Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Non Selective Cox-2 Inhibitors Revenue Growth Rate (2014-2019)
Table Global Cox-2 Inhibitors Revenue by Application (2014-2019)
Table Global Cox-2 Inhibitors Revenue Share by Application (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Share by Application (2014-2019)
Figure Global Cox-2 Inhibitors Revenue Share by Application in 2019
Table Global Cox-2 Inhibitors Revenue Forecast by Application (2019-2024)
Figure Global Cox-2 Inhibitors Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Cox-2 Inhibitors Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cox-2 Inhibitors Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cox-2 Inhibitors Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Europe Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure South America Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cox-2 Inhibitors Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

世界の乾癬性関節炎治療薬市場予測（～2024年）

Global Psoriatic Arthritis Therapeutics Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09D2832 2019年9月11日 123Pages
本調査レポートは、乾癬性関節炎治療薬の世界市場について調べ、まとめました。種類別セグメントは、NF阻害剤、インターロイキン阻害剤、PDE4阻害剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。乾癬性関節炎治療薬の世界市場概観、メーカー動向、メーカー別乾癬性関節炎治...

世界のがんホルモン療法薬市場予測（～2024年）

Global Cancer Hormone Therapy Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3830 2019年9月18日 118Pages
本調査レポートは、がんホルモン療法薬の世界市場について調べ、まとめました。種類別セグメントは、タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン剤、アンドロゲン合成阻害剤、その他等、用途別セグメントは、乳がん、前立腺がん等に区分しました。がんホルモン療法薬の世界市場概観、企業動向、企業別がんホルモン...

世界の腎性全身性線維症（NSF）治療市場予測（～2024年）

Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4156 2019年9月18日 115Pages
本調査レポートは、腎性全身性線維症（NSF）治療の世界市場について調べ、まとめました。種類別セグメントは、血液レオロジー剤、免疫調節薬、アルキル化剤、キナーゼ阻害剤、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。腎性全身性線維症（NSF）治療の世界市場概観、企業動向、企業別腎性...

世界の経口抗糖尿病薬市場予測（～2024年）

Global Oral Antidiabetic Agents Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4177 2019年9月18日 118Pages
本調査レポートは、経口抗糖尿病薬の世界市場について調べ、まとめました。種類別セグメントは、スルホニルウレア、メグリチニド、ビグアナイド、チアゾリジンジオン、アルファグルコシダーゼ阻害剤等、用途別セグメントは、家庭用、医療機関、その他等に区分しました。経口抗糖尿病薬の世界市場概観、企業動向、企業別経口...

世界の炎症性皮膚疾患薬市場予測（～2024年）

Global Inflammatory Skin Diseases Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4030 2019年9月18日 119Pages
本調査レポートは、炎症性皮膚疾患薬の世界市場について調べ、まとめました。種類別セグメントは、レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。炎症性皮膚疾患薬の世界市場概観、企業動向、企業別炎症性皮膚疾患薬シェア...

世界の炎症性皮膚疾患治療市場予測（～2024年）

Global Inflammatory Skin Diseases Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4031 2019年9月18日 117Pages
本調査レポートは、炎症性皮膚疾患治療の世界市場について調べ、まとめました。種類別セグメントは、レチノイド、コルチコステロイド、カルシニューリン阻害剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。炎症性皮膚疾患治療の世界市場概観、企業動向、企業別炎症性皮膚疾患治療...

世界のレビー小体型認知症薬市場予測（～2024年）

Global Lewy Body Dementia Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4078 2019年9月18日 136Pages
本調査レポートは、レビー小体型認知症薬の世界市場について調べ、まとめました。種類別セグメントは、モダフィニル、ベンゾジアゼピン、抗うつ剤、コリンエステラーゼ阻害剤、抗精神病薬、カルビドパ-レボドパ等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。レビー小体型認知症薬の世界市...

世界のレビー小体型認知症治療市場予測（～2024年）

Global Lewy Body Dementia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4079 2019年9月18日 138Pages
本調査レポートは、レビー小体型認知症治療の世界市場について調べ、まとめました。種類別セグメントは、モダフィニル、ベンゾジアゼピン、抗うつ剤、コリンエステラーゼ阻害剤、抗精神病薬、カルビドパ-レボドパ等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。レビー小体型認知症治療の世...

世界のスキンフィラー市場予測（～2024年）

Global Skin Filler Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR09D3166 2019年9月18日 116Pages
本調査レポートは、スキンフィラーの世界市場について調べ、まとめました。種類別セグメントは、HA、CaHA、PLLA、PMMA、その他等、用途別セグメントは、マイクロプラスチック及び化粧品、アンチエイジング、その他等に区分しました。スキンフィラーの世界市場概観、メーカー動向、メーカー別スキンフィラーシ...

世界の薬局オートメーション市場予測（～2024年）

Global Pharmacy Automation Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4198 2019年9月18日 115Pages
本調査レポートは、薬局オートメーションの世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、入院薬局、外来薬局、小売薬局、その他等に区分しました。薬局オートメーションの世界市場概観、企業動向、企業別薬局オートメーションシェア、市場規模推移、市場規模予測（2019年-202...

世界の乾癬性関節炎治療薬市場予測（～2024年） Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin. Scope of the Report: Asia Pacific is antici…
世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…
世界の炎症性皮膚疾患治療市場予測（～2024年） Scope of the Report: The global Inflammatory Skin Diseases Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especiall…
世界の炎症性皮膚疾患薬市場予測（～2024年） Scope of the Report: The global Inflammatory Skin Diseases Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in…
世界の経口抗糖尿病薬市場予測（～2024年） Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhi…